Skip to main content
TAK logo
TAK
(NYSE)
Takeda Pharmaceutical Company Limited
$18.74-- (--)
Loading... - Market loading

Takeda Pharmaceutical Company (TAK) Stock Price & Financial Analysis

Takeda Pharmaceutical Company Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$18.46 - $18.83
52-Week High$18.90
52-Week Low$12.99
Open$18.56
Volume2.64M
Average Volume (3M)2.64M
Market Cap60.06B
Shares Outstanding3.20B
P/E Ratio (TTM)84.91
Forward P/E156.42
Price to Sales (P/S)2.15
Price to Book (P/B)1.25
EV/EBITDA10.79
Revenue (TTM)27.96B
Net Income (TTM)707.27M
Free Cash Flow (TTM)4.68B
EPS (TTM)$0.22
Profit Margin2.53%
Operating Margin11.00%
Return on Equity (ROE)1.48%
Debt to Equity0.64
50-Day MA$17.93
200-Day MA$15.52
52-Week Change25.97%
Annual Dividend$0.32
Dividend Yield1.72%
Payout Ratio145.70%
Last Dividend Ex-DateDec 11, 2026

Frequently Asked Questions About Takeda Pharmaceutical Company

What is the current stock price for TAK?

As of the latest trading session, TAK stock trades at $18.74. The 52-week range is $12.99–$18.90, with a day range of $18.46–$18.83.

What is the P/E ratio for TAK?

Takeda Pharmaceutical Company's trailing P/E ratio is 84.9, meaning investors pay $84.9 for every $1 of annual earnings. The forward P/E is 156.4, reflecting analyst expectations for future earnings. Takeda Pharmaceutical Company operates in the Healthcare sector.

Does TAK pay dividends?

Yes, Takeda Pharmaceutical Company pays a 1.72% annual dividend yield ($0.32 per share). The payout ratio is 145.7%. The last ex-dividend date was 2026-12-11.

What do analysts recommend for TAK?

Analyst ratings and recommendations for TAK are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of TAK?

Takeda Pharmaceutical Company's market capitalization is $60.06B, classifying it as a large-cap company. Takeda Pharmaceutical Company operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.